Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes

Authors:

Abstract
No abstract available
Funding Information
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Roche
  • National Heart, Lung, and Blood Institute (HHSN268201100007C, HHSN2 68201100006C, HHSN268201100011C, HHSN268201100005C, HHSN268201100008C, HHSN26820 1100009C, HHSN268201100010C, HHSN268201 100012C)
  • Donald W. Reynolds Foundation
  • Boehringer Ingelheim
  • Eli Lilly and Company
  • University of Texas Southwestern Medical Center (N01HC 95169, N01-HC-95164, N01-HC-95163, N01-HC-95160, N01-HC-95159, N01-HC-95162, R01 HL071739, N01-HC-95165, N01-HC-95161)
  • Amgen
  • National Institutes of Health (UL1TR001105)
  • Gilead Sciences
  • Food and Drug Administration
  • Novo Nordisk
  • Cytokinetics
  • National Center for Advancing Translational Sciences

This publication has 39 references indexed in Scilit: